Take it easy, there are people supporting your opinion and the fact IHL has always been highly speculative and heavily manipulated in 2021-2022. The good thing is low SP eradicated the plethora of up-pumpers who talked about 500 bln addressable market. As if the other bio-tech companies are not interested to penetrate and develop in it. When MM and another few stop writing here, then we can call it a bottom.
General discussion, page-14891
-
- There are more pages in this discussion • 5,585 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)